HealthStream vs Solventum
Add, change or remove companies; up to four.
The short version
- Solventum is the larger business, with $8.3B of revenue in fiscal 2025 against $304M for HealthStream, about 27 times as much.
- HealthStream grew revenue faster (4.3%, against 0.9%).
- Solventum kept more of each dollar of sales as operating profit (26.2% operating margin, against 6.7%).
- HealthStream turned more of its sales into free cash flow (19.6% FCF margin, against −0.1%).
- Investors pay more for each dollar of HealthStream’s earnings: a P/E of 48.8x against 10.5x for Solventum.
| Latest fiscal year | HSTM · FY25 | SOLV · FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.0B | $14.8B |
| Revenue | $304M | $8.3B |
| Free cash flow | $59.6M | −$10.0M |
| Net income | $18.3M | $1.6B |
| Growth | ||
| Revenue growth | 4.3% | 0.9% |
| 5-year growth | 4.4% | — |
| Share count change | −1.3% | 0.9% |
| Profitability | ||
| Gross margin | — | 53.5% |
| Operating margin | 6.7% | 26.2% |
| Net margin | 6.0% | 18.7% |
| FCF margin | 19.6% | −0.1% |
| Return on capital | — | 20.4% |
| Return on equity | 5.1% | 38.9% |
| Balance sheet | ||
| Net debt | — | $4.2B |
| Net debt / EBITDA | — | 1.6x |
| Dividends and buybacks | $33.7M | $0.0M |
| Valuation & quality | ||
| P/E | 48.8x | 10.5x |
| Piotroski F-score | — | 5 |
Revenue
FY16
HSTM $192M
SOLV —
FY17
HSTM $215M
SOLV —
FY18
HSTM $232M
SOLV —
FY19
HSTM $254M
SOLV —
FY20
HSTM $245M
SOLV —
FY21
HSTM $257M
SOLV —
FY22
HSTM $267M
SOLV $8.1B
FY23
HSTM $279M
SOLV $8.2B
FY24
HSTM $292M
SOLV $8.3B
FY25
HSTM $304M
SOLV $8.3B
HSTM
SOLV
Operating margin
FY16
HSTM 3.7%
SOLV —
FY17
HSTM 4.4%
SOLV —
FY18
HSTM 6.7%
SOLV —
FY19
HSTM 5.8%
SOLV —
FY20
HSTM 6.5%
SOLV —
FY21
HSTM 3.1%
SOLV —
FY22
HSTM 4.7%
SOLV 20.8%
FY23
HSTM 5.7%
SOLV 20.6%
FY24
HSTM 7.3%
SOLV 12.6%
FY25
HSTM 6.7%
SOLV 26.2%
HSTM
SOLV
Free cash flow
FY16
HSTM $19.4M
SOLV —
FY17
HSTM $41.2M
SOLV —
FY18
HSTM $36.1M
SOLV —
FY19
HSTM $43.7M
SOLV —
FY20
HSTM $33.9M
SOLV —
FY21
HSTM $39.0M
SOLV —
FY22
HSTM $49.4M
SOLV $1.4B
FY23
HSTM $61.8M
SOLV $1.6B
FY24
HSTM $56.3M
SOLV $805M
FY25
HSTM $59.6M
SOLV −$10.0M
HSTM
SOLV
Return on capital
FY16
HSTM —
SOLV —
FY17
HSTM —
SOLV —
FY18
HSTM —
SOLV —
FY19
HSTM —
SOLV —
FY20
HSTM —
SOLV —
FY21
HSTM —
SOLV —
FY22
HSTM —
SOLV —
FY23
HSTM —
SOLV —
FY24
HSTM —
SOLV 7.6%
FY25
HSTM —
SOLV 20.4%
HSTM
SOLV
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.